Researchers have discovered that investigational cancer drug, BEZ235, may reduce the severity of influenza infection by altering host-cell metabolism, representing new treatment avenues.
Recent studies suggest that the risk of a heart attack could be increased 17-fold during the 7 days after a respiratory infection.
Researchers have developed a transgenic mouse model to identify influenza A strains with the potential to cause a global pandemic.
Despite an urgent need for a universal flu vaccine there is no such vaccine in the market and no regulatory guideline for its approval. This special report from Future Virology proposes a stepwise process for regulatory and marketing approval for such a vaccine and discusses the epitope-based vaccine candidate Multimeric-001 (M-001).
New study in mouse models suggests immune adaptation in pregnancy reduces the antiviral response allowing the influenza virus to mutate to more virulent strains and causing more severe infections.
The first study to investigate attitudes to the child flu vaccine in the UK has reported that concerns around the vaccines safety, efficiency and side effects may be reducing uptake.
We at Infectious Diseases Hub recently spoke to Peter Openshaw, Professor of Experimental Medicine at Imperial College London (UK), about his research into respiratory viruses and the challenges currently facing science policy and funding.
A new meta-analysis has presented findings reporting that regular vitamin D supplementation could drastically lower the risk of acute respiratory infections.
The authors of this editorial look back over the work that has been conducted towards developing a universal vaccine for influenza.
